Julie M. Janssen - Concepedia

Author

Julie M. Janssen

Also Known As

J P Kuyvenhoven, J. Janssen, J. M. Janssen, J.M. Janssen, Janssen, Julie M, Julie Janssen, Julie M. Janssen, Rajneet Oberoi

Publications

592

Citations

H-Index

Concepts

All Affiliations

The Netherlands Cancer Institute Utrecht University University Medical Center Utrecht Radboud University Nijmegen Oncode Institute

About

Julie M. Janssen is an author at The Netherlands Cancer Institute specializing in medicine, pharmacology, and patient safety.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	349
2	Pharmacology	2	2	79
3	Emergency Medicine	1	1	270
4	Obstetrics	1	1	25
5	Antibiotics	1	1	270

Julie M. Janssen

Publications

504

Citations

H-Index

Page 1

	Year	Citations
Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial Nadia Alam, Erick Oskam, Patricia M. Stassen, The Lancet Respiratory Medicine Open LabelAntimicrobial StewardshipAntibioticsMedicineHealthcare-associated Infection	2017	270
Development and validation of a liquid chromatography-tandem mass spectrometry assay for nine oral anticancer drugs in human plasma Julie M. Janssen, Niels de Vries, Nikkie Venekamp, Journal of Pharmaceutical and Biomedical Analysis Oral Anticancer DrugsGas ChromatographyMedicineDrug DiscoveryBioanalysis	2019	54
Exposure–Response Analyses of Anaplastic Lymphoma Kinase Inhibitors Crizotinib and Alectinib in Non‐Small Cell Lung Cancer Patients Stefanie L. Groenland, D. R. Geel, Julie M. Janssen, Clinical Pharmacology & Therapeutics	2020	46
Therapeutic Drug Monitoring of Gentamicin Peak Concentrations in Critically Ill Patients Caspar J. Hodiamont, Julie M. Janssen, Menno D. de Jong, Therapeutic Drug Monitoring	2017	27
Population Pharmacokinetics of Docetaxel, Paclitaxel, Doxorubicin and Epirubicin in Pregnant Women with Cancer: A Study from the International Network of Cancer, Infertility and Pregnancy (INCIP) Julie M. Janssen, Kristel Van Calsteren, Thomas P. C. Dorlo, Clinical Pharmacokinetics OncologyMedicineGynecologyPregnant WomenPharmacotherapy	2021	25
Evaluation of Extrapolation Methods to Predict Trough Concentrations to Guide Therapeutic Drug Monitoring of Oral Anticancer Drugs Julie M. Janssen, Thomas P. C. Dorlo, Jos H. Beijnen, Therapeutic Drug Monitoring	2020	23
Longitudinal nonlinear mixed effects modeling of <scp>EGFR</scp> mutations in <scp>ctDNA</scp> as predictor of disease progression in treatment of <scp>EGFR</scp>‐mutant non‐small cell lung cancer Julie M. Janssen, Remy B. Verheijen, Tirsa T van Duijl, Clinical and Translational Science	2022	20
Therapeutic drug monitoring of small molecule kinase inhibitors in oncology in a real‐world cohort study: does age matter? Marie‐Rose B. S. Crombag, Jacobine G. C. van Doremalen, Julie M. Janssen, British Journal of Clinical Pharmacology	2018	15
A Population Pharmacokinetic Model of Oral Docetaxel Coadministered With Ritonavir to Support Early Clinical Development Huixin Yu, Julie M. Janssen, Emilia Sawicki, The Journal of Clinical Pharmacology	2019	12
<scp>ModraDoc006</scp>, an oral docetaxel formulation in combination with ritonavir (<scp>ModraDoc006</scp>/r), in metastatic castration‐resistant prostate cancer patients: A phase Ib study Marit A. C. Vermunt, Debbie Robbrecht, Lot A. Devriese, Cancer Reports	2021	12

Page 1